Mechanistically, hepatocyte SIRT6 likely inhibited the development of NAFLD by inhibiting lipogenesis, lipid droplet formation, and p53 signaling. This evidence concerns the gene SIRT6 and metabolic dysfunction-associated steatotic liver disease.